Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT in Pediatric Crohn's Disease
NCT02272868Phase 2Terminated
- Sponsor
- Seattle Children's
- Start
- Jan 2015
- Primary completion
- Oct 2016
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fecal microbiome transplant in Crohn's disease, sponsored by Seattle Children's. Primary endpoint: Pediatric Crohn's Disease Activity Index at 12 weeks. Started Jan 2015; status: terminated.
02
Drugs
fecal microbiome transplant
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02272868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02272868.